Genentech to Continue Avastin Trial
Stock quotes in this article:
DNA
"There are current chemotherapy options for patients with early stage colon cancer, but there are still patients who relapse," said Genentech spokeswoman Kirstina Becker Monday morning. "We believe the science supports the potential role of Avastin in adjuvant colon cancer and hope it will be shown to help keep more people's cancer from coming back."
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,414.14 | 1,114.05 | 2,237.66 | 36.82 |
Oil *
72.73
|
|
UP
85.25
|
UP
11.58
|
UP
25.97
|
UP
1.36
|
10 Yr
3.68%
SPDR Gold
106.95
|
|
+0.83%
|
+1.05%
|
+1.17%
|
+3.84%
|
Data delayed 20 minutes |
